Fragment-based exploration of the 14-3-3/Amot-p130 interface
The modulation of protein-protein interactions (PPIs) has developed into a well-established field of drug discovery. Despite the advances achieved in the field, many PPIs are still deemed as ‘undruggable’ targets and the design of PPIs stabilizers remains a significant challenge. The application of...
Main Authors: | Federica Centorrino, Blaž Andlovic, Peter Cossar, Luc Brunsveld, Christian Ottmann |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-01-01
|
Series: | Current Research in Structural Biology |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2665928X21000337 |
Similar Items
-
Modulation of E-Cadherin Function through the AmotL2 Isoforms Promotes Ameboid Cell Invasion
by: Aravindh Subramani, et al.
Published: (2023-06-01) -
Ambiguity about Splicing Factor 3b Subunit 3 (SF3B3) and Sin3A Associated Protein 130 (SAP130)
by: Paula I. Metselaar, et al.
Published: (2021-03-01) -
FKBP51, AmotL2 and IQGAP1 Involvement in Cilastatin Prevention of Cisplatin-Induced Tubular Nephrotoxicity in Rats
by: Rebeca González-Fernández, et al.
Published: (2022-05-01) -
14-3-3: A Case Study in PPI Modulation
by: Alice Ballone, et al.
Published: (2018-06-01) -
Room-temperature crystallography reveals altered binding of small-molecule fragments to PTP1B
by: Tamar Skaist Mehlman, et al.
Published: (2023-03-01)